Hemochromatosis and Wilson's disease;Hamochromatose und morbus Wilson

Internist

Volumn 40, Issue 5, 1999, Pages 513-521

  Herrmann, T ^a   Smolarek, C ^a   Gehrke, S ^a   Schafer M ^a   Stremmel, W ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLAMINE; TRIENTINE; ZINC ACETATE; ZINC SULFATE;

HEMOCHROMATOSIS; HUMAN; PATHOGENESIS; PROGNOSIS; REVIEW; WILSON DISEASE; CHROMOSOME ABERRATION; CHROMOSOME DISORDER; GENETICS; HETEROZYGOTE DETECTION; RECESSIVE GENE;

CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; GENES, RECESSIVE; HEMOCHROMATOSIS; HEPATOLENTICULAR DEGENERATION; HETEROZYGOTE DETECTION; HUMANS; PROGNOSIS;

EID: 0032909354     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050365     Document Type: Review

References (44)

1. Adams PC, Valdberg LS (1996) Evolving expression of hemochromatosis. Semin Liver Dis 16:47-54
2. Bacon BR, Britton RS (1990) The pathology of hepatic iron overload: A free radical-mediated process? Hepatology 11:127-137
3. Beutler E, Gelbart T, West C, Lee P, Adams M, Blackstone R, Pockros P, Kosty M, Venditti CP, Phatak PD, Seese NK, Chorney KA, Ten Elshof AE, Gerhard GS, Chorney M (1996) Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis 22:187-194
4. Beutler E (1997) Genetic beyond haemochromatosis: Clinical effects of HLA-H mutations. Lancet 349:296-297
5. Brewer GJ, Hill GJ, Prasad AS, Cossack ZT, Rabbani P (1983) Treatment of Wilson's disease with zinc. Ann Intern Med 99:314-319
6. Brewer GJ, Terry CA, Aisen AM, Hill GM (1987) Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol 44:490-493
7. Brewer GJ, Yuzbasiyan-Gurkan V (1992) Wilson disease. Medicine 71:139-164
8. Brewer GJ (1995) Practical recommendations and new therapies for Wilson's disease. Drugs 50:240-249
9. Chen GL, Chen YS, Lui CC, Hsu SP (1997) Neurological improvement of Wilson's disease after liver transplantation. Transplant Proc 29:497-498
10. Dabestani A, Child JS, Henze E, Perlof JK, Schon H, Figueroa WG, Schelbert RH, Thressomboon S (1984) Primary hemochromatosis: Anatomic and physiologic characteristics of the cardiac ventricles and their response to phlebotomy. Am J Cardiol 54:153-159
11. Dahlmann T, Hartvig P, Lofholm M, Nordlinder H, Loof L (1995) Longterm treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine). QJM 88:609-616
12. Feder J, Gnirke W, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzmann RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK (1996) A novel MHC class l-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet 13:399-408
13. Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, Tsuchihashi Z, Sigal E, Bjorkman PJ, Schatzman RC (1998) The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 95:1472-1477
14. Gollan JL, Gollan TJ (1998) Wilson disease in 1998: Genetic, diagnostic and therapeutic aspects. J Hepatol 28 [Suppl 1]:28-36
15. Hamilton EBD, Bomford AB, Laws JW, Williams R (1982) The natural history of arthritis in idiopathic hemochromatosis: Progression of the clinical and radiologic features over ten years. Quart J Med NS 199:321-329
16. Jouanolle AM, Gandon G, Jézéquel P, Blayau M, Campion ML, Yaouanq J, Mosser J, Fergelot P, Chauvel B, Bouric P, Carn G, Andrieux N, Gicquel I, Le Gall J-Y, David V (1996) Haemochromatosis and HLA-H. Nat Genet 14:251-252
17. Kowdley KV, Trainer TD, Saltzman JR, Pedrosa M, Krawitt EL, Knox TA, Susskind K, Pratt D, Bonkovsky HL, Grace ND, Kaplan MM (1997) Utility of hepatic iron index in American patients with hereditary hemochromatosis: A multicenter study. Gastroenterology 113:1270-1277
18. Ludwig J, Moyer TP, Rakela J (1991) The liver biopsy diagnosis of Wilson's disease. Methods in pathology. Am J Clin Pathol 102:443-446
19. Miyazaki JI, Apella E, Ozato K (1996) Intracellular transport blockade caused by disruption of the disulfid bridge in the third external domain of major histocompatibility complex class I antigen. Proc Nat Acad Sci USA 83:757-761
20. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G (1985) Survival and causes of death in cirrhotic and noncirrhotic patients with primary hemochromatosis. N Engl J Med 313:1256-1262
21. Niederau C, Fischer R, Pürschel A, Stremmel W, Häussinger D, Strohmeyer G (1996) Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 110:1107-1119
22. Oder W, Grimm G, Kollegger H, Ferenci P, Schneider B, Deecke L (1991) Neurological and neuropsychiatric spectrum of Wilson's disease: A prospective study of 45 cases. J Neurol 238:281-287
23. Parkkila S, Waheed A, Britton RS, Bacon BR, Zhou XY, Tomatsu S, Fleming RE, Sly WS (1997) Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 94:13198-13202
24. Payne AS, Kelly EJ, Gitlin JD (1998) Functional expression of the Wilson disease protein reveals mislocalization and impaired copper dependent trafficking of the common H1069Q mutation. Proc Natl Acad Sci USA 95:10854-10859
25. Piperno A, Sampietro M, Pietrangelo A, Arosio C, Lupica L, Montosi G, Vergani A, Fraquelli M, Girelli D, Pasquero P, Roetto A, Gasparini P, Fargion S, Conte D, Camaschella C (1998) Heterogeneity of hemochromatosis in Italy. Gastroenterology 114:996-1002
26. Rela M, Heaton ND, Vougas V, McEntee G, Gane E, Farhat B, Chiyende J, Mieli-Vergani G, Mowat AP, Portmann B (1993) Orthotopic liver transplantation for hepatic complications of Wilson's disease. Br J Surg 80:909-911
27. Riedel HD, Fitscher BA, Hefter H, Stohmeyer G, Stremmel W (1994) Klonierung des morbus-Wilson-gens. Z Gastroenterol 32:472-473
28. Schäfer M (1998) Aktuelle aspekte zur pathogenese des morbus Wilson. Verdauungskrankheiten 16:237-241
29. Schaefer M, Gitlin JD (1999) Genetic disorders of copper transport. Am J Physiol (in press)
30. Schilsky ML (1996) Wilson disease: Genetic basis of copper toxicity and natural history. Semin Liver Dis 16:83-95
31. Schilsky ML, Scheinberg IH, Sternlieb I (1994) Liver transplantation for Wilson's disease: Indications and outcome. Hepatology 19:583-587
32. Schumacher G, Platz KP, Mueller AR, Neuhaus R, Steinmüller T, Bechstein WO, Becker M, Luck W, Schuelke M, Neuhaus P (1997) Liver transplantation: Treatment of choice for hepatic and neurological manifestation of Wilson's disease. Clin Transplant 11:217-224
33. Shah AB, Chernov I, Zhang HT, Ross BM, Das K, Lutsenko S, Parano E, Evgrafov O, Ivanova-Smolenskaya IA, Anneren G, Westermark K, Urrutia FH, Penchaszadeh GK, Sternlieb I, Scheinberg IH, Gilliam TC, Petrukhin K (1997) Identification and analysis of mutations in the Wilson disease gene (ATP7B): Population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Gen 61:317-328
34. Simon M, Bourel M, Fauchet R, Genetet B (1976) Association of HLA-A3 and HLA-B14 antigens wih idiopathic haemochromatosis. Gut 17:332-334
35. Strand S, Hofmann WJ, Grambihler A, Hug H, Volkmann M, Otto G, Wesch H, Mariani SM, Hack V, Stremmel W, Krammer PH, Galle PR (1998) Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med 4:588-593
36. Stremmel W, Niederau C, Berger M, Kley HK, Krüskemper HL, Strohmeyer G (1988) Abnormalities in estrogen, androgen, insulin metabolism in idiopathic hemochromatosis. Ann NY Acad Sci 526:209-223
37. Stremmel W, Meyerrose KM, Niederau C, Hefter H, Kreuzpainter G, Strohmeyer G (1991) Wilson disease: Clinical presentation, treatment and survival. Ann Intern Med 115:720-726
38. Stremmel W, Niederau C, Strohmeyer G (1993) Therapie der Hämochromatose. Dtsch Med Wschr 118:267-269
39. Stremmel W, Riedel HD, Niederau C, Strohmeyer G (1993) Pathogenesis of genetic haemochromatosis. Eur J Clin Invest 23:321-329
40. Stremmel W (1996) Aktuelle diagnostik: Hereditäre stoffwechselerkrankungen der leber (primäre hämochromatose, morbus Wilson). Schw Rundsch Med (Praxis) 85:1513-1517
41. Turnland JR (1998) Human whole-body copper metabolism. Am J Clin Nutr 67:960S-964S
42. Walshe JM (1987) The liver in Wilson's disease (hepatolenticular degeneration). In Schiff L, Schiff ER (eds) Diseases of the Liver. 6th Ed. Philadelphia: JB Lippincott, pp 1037-1042
43. Yarze JC, Martin P, Munoz SJ, Friedman IS (1992) Wilson's disease: Current status. Am J Med 92:643-654
44. Yuzbasiyan-Gurkan V, Grider A, Nostrant V, Cousins RJ, Brewer GJ (1992) Treatment of Wilson's disease with Zinc X. Intestinal metallothionein induction. J Lab Clin Med 12:380-386